Eligibility for antiviral therapy and treatment uptake in chronic hepatitis B patients referred to a European tertiary care center

BACKGROUND AND AIMS: Treatment indications for chronic hepatitis B (CHB) differ among recommendations by European Association for the Study of the Liver (EASL), American Association for the Study of Liver Diseases (AASLD) and World Health Organization (WHO). We aimed to assess treatment eligibility...

Descripción completa

Detalles Bibliográficos
Autores principales: Jachs, Mathias, Sauberer, Raphael, Stiegler, Alexander, Dechêne, Anton, Tazreiter, Raphael, Hartl, Lukas, Bauer, David, Balcar, Lorenz, Strassl, Robert, Mandorfer, Mattias, Trauner, Michael, Munda, Petra, Ferenci, Peter, Reiberger, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Hepatobiliary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083468/
https://www.ncbi.nlm.nih.gov/pubmed/36965148
http://dx.doi.org/10.1002/ueg2.12376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083468/
https://www.ncbi.nlm.nih.gov/pubmed/36965148
http://dx.doi.org/10.1002/ueg2.12376

Ejemplares similares